Combination of a strategy to prolong dendritic cell survival and a strategy to bypass antigen processing enhances DNA vaccine potency.

被引:0
|
作者
Huang, BK [1 ]
Peng, SW [1 ]
Huang, CH [1 ]
He, LM [1 ]
Hung, CF [1 ]
Wu, TC [1 ]
机构
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2747S / 2747S
页数:1
相关论文
共 23 条
  • [1] Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency
    Huang, Bruce
    Mao, Chih-Ping
    Peng, Shiwen
    He, Liangmei
    Hung, Chien-Fu
    Wu, T. -C.
    VACCINE, 2007, 25 (45) : 7824 - 7831
  • [2] Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies
    Kim, TW
    Hung, CF
    Boyd, D
    Juang, J
    He, LM
    Kim, JW
    Hardwick, JM
    Wu, TC
    JOURNAL OF IMMUNOLOGY, 2003, 171 (06): : 2970 - 2976
  • [3] Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments
    Kang, Tae Heung
    Lee, Jin Hyup
    Noh, Kyung Hee
    Han, Hee Dong
    Shin, Byung Cheol
    Choi, Eun Young
    Peng, Shiwen
    Hung, Chien-Fu
    Wu, T. -C.
    Kim, Tae Woo
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (08) : 1696 - 1703
  • [4] Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life and intracellular targeting strategies with a strategy to boost CD4+ T cells
    Kim, Daejin
    Hoory, Talia
    Wu, T. -C.
    Hung, Chien-Fu
    HUMAN GENE THERAPY, 2007, 18 (11) : 1129 - 1139
  • [5] Fusion of antigen to chemokine CCL20 or CXCL13 strategy to enhance DNA vaccine potency
    Guo, Ji Hua
    Fan, Ming Wen
    Sun, Jing Hua
    Jia, Rong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (7-8) : 925 - 930
  • [6] Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine
    Shi, Gao-Na
    Hu, Min
    Chen, Chengjuan
    Fu, Junmin
    Shao, Shuai
    Zhou, Yu
    Wu, Lei
    Zhang, Tiantai
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [7] Characterization of donor dendritic cells and enhancement of dendritic cell efflux with cc-chemokine ligand 21 - A novel strategy to prolong islet allograft survival
    Fiorina, Paolo
    Jurewicz, Mollie
    Tanaka, Katsunori
    Behazin, Negin
    Augello, Andrea
    Vergani, Andrea
    Von Adrian, Uli
    Smith, Neal R.
    Sayegh, Mohamed H.
    Abdi, Reza
    DIABETES, 2007, 56 (04) : 912 - 920
  • [8] RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency
    S-T Wang
    C-C Chang
    M-C Yen
    C-F Tu
    C-L Chu
    Y-T Peng
    D-Y Chen
    J-L Lan
    C-C Lin
    Gene Therapy, 2011, 18 : 372 - 383
  • [9] RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency
    Wang, S-T
    Chang, C-C
    Yen, M-C
    Tu, C-F
    Chu, C-L
    Peng, Y-T
    Chen, D-Y
    Lan, J-L
    Lin, C-C
    GENE THERAPY, 2011, 18 (04) : 372 - 383
  • [10] Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine
    Ohshio, Yasuhiko
    Teramoto, Koji
    Hanaoka, Jun
    Tezuka, Noriaki
    Itoh, Yasushi
    Asai, Tohru
    Daigo, Yataro
    Ogasawara, Kazumasa
    CANCER SCIENCE, 2015, 106 (02) : 134 - 142